重组凝血因子VIIa与凝血因子VIII抑制剂旁路活性输注后的血栓形成事件发生率比较——反驳意见 - Suppr

Suppr

超能文献

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity--a rebuttal.

作者信息

Sallah S, Isaksen M, Seremetis S, Payne Rojkjaer L

出版信息

J Thromb Haemost. 2005 Apr;3(4):820-2; author reply 822. doi: 10.1111/j.1538-7836.2005.01254.x.

DOI:10.1111/j.1538-7836.2005.01254.x

PMID:15842389

Abstract

摘要

相似文献

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity--a rebuttal.

J Thromb Haemost. 2005 Apr;3(4):820-2; author reply 822. doi: 10.1111/j.1538-7836.2005.01254.x.

Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity--a rebuttal.

J Thromb Haemost. 2005 Apr;3(4):818-9; author reply 819. doi: 10.1111/j.1538-7836.2005.01201.x.

Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.

J Thromb Haemost. 2004 Oct;2(10):1700-8. doi: 10.1111/j.1538-7836.2004.00944.x.

Thrombosis and recombinant factor VIIa.

J Thromb Haemost. 2004 Oct;2(10):1698-9. doi: 10.1111/j.1538-7836.2004.00943.x.

Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.

Semin Cardiothorac Vasc Anesth. 2007 Dec;11(4):261-4. doi: 10.1177/1089253207311357.

Continuous infusion of recombinant factor VIIa: continue or not?

Thromb Haemost. 2001 Oct;86(4):942-4.

Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.

Thromb Haemost. 2002 May;87(5):925-6.

Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.

Crit Care. 2011;15(2):407. doi: 10.1186/cc10041. Epub 2011 Mar 9.

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group.

Haemophilia. 1998 Jul;4(4):564-7. doi: 10.1046/j.1365-2516.1998.440564.x.

Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.

Anesth Analg. 2017 May;124(5):1431-1436. doi: 10.1213/ANE.0000000000001947.

引用本文的文献

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.

Vasc Health Risk Manag. 2007;3(5):655-64.

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.

Vasc Health Risk Manag. 2007;3(4):527-31.

Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Drugs. 2005;65(8):1161-77. doi: 10.2165/00003495-200565080-00008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity--a rebuttal.

作者信息

Sallah S, Isaksen M, Seremetis S, Payne Rojkjaer L

出版信息

J Thromb Haemost. 2005 Apr;3(4):820-2; author reply 822. doi: 10.1111/j.1538-7836.2005.01254.x.

DOI:10.1111/j.1538-7836.2005.01254.x

PMID:15842389

Abstract

摘要